Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Harriette Van Spall , Roland RJ van Kimmenade Added: 1 year ago
ACC 25 - FRESH-UP shows liberal fluid intake did not result in a significant difference in health status compared to fluid restriction of 1500ml per day, but did result in a lower perceived thirst distress.Dr Harriette Van Spall (McMaster University, CA) sits down with Dr Roland Van Kimmenade (Radboud University Medical Center, Nijmegen, NL) to discuss the findings from the multi-center,… View more
Author(s): Eugene Braunwald , Harriette Van Spall Added: 2 months ago
In this Radcliffe Cardiology Masterclass, Dr Harriette Van Spall (McMaster University, Canada) sits down with cardiology legend Dr Eugene Braunwald (Harvard Medical School, TIMI Study Group) to explore his life, landmark research, and advice for the next generation of cardiovascular clinicians and scientists. This discussion was originally recorded in 2021, and we share it now in remembrance of… View more
Dr Lorcan Ruane recently completed a cardio-oncology fellowship at the Royal Brompton Hospital in London. He was trained in general cardiology in Brisbane, Australia and has also completed a fellowship in advanced echocardiography. His cardio-oncology interests include immunotherapy toxicities, cardiotoxicity monitoring and survivorship. Dr Ruane has now returned to Brisbane where he is building… View more
Job title: Consultant Cardiologist
Prof Sabine Ernst is a cardiac electrophysiologist with special expertise in complex arrhythmias, such as atrial fibrillation and ventricular arrhythmia in both paediatric and adult patients. She is a Consultant Cardiologist at NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and National Heart and Lung Institute, Imperial College London & Harefield NHS Foundation Trust. She has been… View more
Author(s): Nir Uriel Added: 9 months ago
HFSA 25 - CCM-D was associated with successful defibrillation and symptom improvement in patients with HFrEF at 6 months in the INTEGRA-D Trial.Dr Nir Uriel (NewYork-Presbyterian, Columbia University Irving Medical Center, US) joins us to discuss findings from the Integra-D trial, evaluating a novel implantable device that provides both cardiac contractility modulation and defibrillation… View more
Author(s): Barry Borlaug Added: 9 months ago
HFSA 25 - Sex-specific outcomes of tirzepatide in obesity-related HFpEF showed that at baseline, women with HFpEF had more severe heart failure symptoms.Dr Barry Borlaug (Mayo Clinic, US) joins us to discuss a prespecified secondary analysis from the SUMMIT trial, examining sex-specific effects of tirzepatide in patients with heart failure with preserved ejection fraction and obesity.The SUMMIT… View more
Author(s): Gregg Stone Added: 1 year ago
THT Conference 2025 - Outcomes after heart failure patients were treated with an interatrial shunt show heart failure with reduced ejection fraction (HFrEF) patients had further benefit compared to heart failure with preserved ejection fraction (HFpEF) patients. The study's prediction model revealed four independent predictors of two-year adverse outcomes in HFrEF patients treated with medical… View more
Research Area(s) / Expertise: Job title: Professor of Cardiology & Cardiac Imaging and Consultant Cardiologist
Dipak Kotecha is a Professor of Cardiology at the University of Birmingham, and a Consultant Cardiologist specialising in cardiac imaging. He has completed a prestigious National Institute for Health Research (NIHR) Fellowship and was awarded the British Cardiovascular Society, Michael Davies Medal, in 2018 for his contribution to cardiovascular medicine. He works extensively across the European… View more